Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wei, Chunli ^a,b   Cheng, Jingliang ^a   Zhou, Boxv ^a   Zhu, Li ^a   Khan, Md Asaduzzaman ^a   He, Tao ^a   Zhou, Sufang ^c   He, Jian ^c   Lu, Xiaoling ^c   Chen, Hanchun ^d   Zhang, Dianzheng ^e   Zhao, Yongxiang ^c   Fu, Junjiang ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; NUCLEAR PROTEIN; PROTEIN BINDING; TRANSCRIPTION INTERMEDIARY FACTOR 1 BETA; TRIM28 PROTEIN, HUMAN; TWIST RELATED PROTEIN 1; TWIST1 PROTEIN, HUMAN;

ADULT; AGED; BREAST TUMOR; CELL LINE; CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; MCF-7 CELL LINE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ADULT; AGED; BREAST NEOPLASMS; CADHERINS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MCF-7 CELLS; MIDDLE AGED; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROTEIN BINDING; RNA INTERFERENCE; TRIPARTITE MOTIF-CONTAINING PROTEIN 28; TWIST-RELATED PROTEIN 1;

EID: 84978842100     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29822     Document Type: Article

References (43)

1. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7), 927-939 (2004).
2. Kang, Y. & Massagué, J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118, 277-279 (2004).
3. Khan, M. A., Chen, H. C., Zhang, D. & Fu, J. Twist: a molecular target in cancer therapeutics. Tumor Biol 34, 2497-2506 (2013).
4. Pinho, A. V., Rooman, I. & Real, F. X. p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle 10, 1312-1321 (2011).
5. Yang, J. & Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14, 818-829 (2008).
6. Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890 (2009).
7. Fu, J. et al. The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res 21(2), 275-289 (2011).
8. Tania, M., Khan, M. A. & Fu, J. Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumour Biol 35, 7335-7342 (2014).
9. Galván, J. A. et al. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelialmesenchymal transition-like tumor budding phenotype in colorectal cancer. Oncotarget 6(2), 874-885 (2015).
10. Bourgeois, P., Stoetzel, C., Bolcato-Bellemin, A. L., Mattei, M. G. & Perrin-Schmitt, F. The human H-twist gene is located at 7p21 and encodes a B-HLH protein that is 96% similar to its murine M-twist counterpart. Mamm Genome 7, 915-917 (1996).
11. Howard, T. D. et al. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 15, 36-41 (1997).
12. el Ghouzzi, V. et al. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15(1), 42-46 (1997).
13. James, P. A. et al. Breast cancer risk is not increased in individuals with TWIST1 mutation confirmed Saethre-Chotzen syndrome: an Australian multicenter study. Genes Chromosomes Cancer 48(7), 533-538 (2009).
14. Cheng, C. T., Kuo, C. Y. & Ann, D. K. KAPtain in charge of multiple missions: Emerging roles of KAP1. World J Biol Chem 5, 308-320 (2014).
15. Iyengar, S. & Farnham, P. J. KAP1 protein: an enigmatic master regulator of the genome. J Biol Chem 286(30), 26267-2676 (2011).
16. Bunch, H. et al. TRIM28 regulates RNA polymerase II promoter-proximal pausing and pause release. Nat Struct Mol Biol 21(10), 876-883 (2014).
17. Bunch, H. & Calderwood, S. K. TRIM28 as a novel transcriptional elongation factor. BMC Mol Biol 16(1), 14 (2015).
18. Wang, C. et al. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J 24, 3279-3290 (2005).
19. Chu, Y. & Yang, X. SUMO E3 ligase activity of TRIM proteins. Oncogene 30, 1108-1116 (2011).
20. Okamoto, K., Kitabayashi, I. & Taya, Y. KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction. Biochem Biophys Res Commun 351(1), 216-222 (2006).
21. Poyurovsky, M. V. et al. Nucleotide binding by the Mdm2 RING domain facilitates Arf-independent Mdm2 nucleolar localization. Mol Cell 12(4), 875-887 (2003).
22. Addison, J. B. et al. KAP1 promotes proliferation and metastatic progression of breast cancer cells. Cancer Res 75, 344-355 (2015).
23. Venkov, C. D. et al. A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest 117, 482-491 (2007).
24. Chen, L., Muñoz-Antonia, T. & Cress, W. D. Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines. PLoS One 9, e101040 (2014).
25. Kim, W. J. et al. The WTX Tumor Suppressor Interacts with the Transcriptional Corepressor TRIM28.J Biol Chem 290, 14381-14390 (2015).
26. Hu, G. et al. A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev 23, 837-848 (2009).
27. Seki, Y. et al. TIF1beta regulates the pluripotency of embryonic stem cells in aphosphorylation-dependent manner. PNAS USA 107(24), 10926-10931 (2010).
28. Neo, S. H. et al. TRIM28 is an E3 ligase for ARF-mediated NPM1/B23 SUMOylation that represses centrosome amplification. Mol Cell Biol 35, 2851-63 (2015).
29. Pineda, C. T. & Potts, P. R. Oncogenic MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by ubiquitinating and degrading AMPK in cancer. Autophagy 11, 844-846 (2015).
30. Yokoe, T. et al. KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol 17, 821-828 (2010).
31. Yu, C. et al. KAP-1 is overexpressed and correlates with increased metastatic ability and tumorigenicity in pancreatic cancer. Med Oncol 31, 25-34 (2014).
32. Cui, Y. et al. High levels of KAP1 expression are associated with aggressive clinical features in ovarian cancer. Int J Mol Sci 16, 363-377 (2014).
33. Chen, L. et al. Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions. J Biol Chem 287, 40106-40118 (2012).
34. Van Meter, M. et al. SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age. Nat Commun 5, 5011 (2014).
35. Khan, M. A. et al. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition. Oncotarget 6, 19580-19591 (2015).
36. Kajiro, M. et al. The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways. Nat Cell Biol 11, 312-319 (2009).
37. Yang, M. H. et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 12, 982-992 (2010).
38. Gort, E. H. et al. The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene 27, 1501-1510 (2008).
39. Fu, J. et al. TWIST represses estrogen receptor-alpha expression by recruiting the NuRD protein complex in breast cancer cells. Int J Biol Sci 8, 522-532 (2012).
40. Li, L. et al. REGγ is critical for skin carcinogenesis by modulating the Wnt/β-catenin pathway. Nat Commun 6, 6875 (2015).
41. Liu, X. et al. Establishment of stable cell line for inducing KAP1 protein expression. Acta Biol Hung 6, 161-168 (2015).
42. Fu, J., Yoon, H. G., Qin. J. & Wong, J. Regulation of P-TEFb elongation complex activity by CDK9 acetylation. Mol Cell Biol 27, 4641-4651 (2007).
43. Li, C. et al. Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3AIB. Oncogene 30, 4350-4364 (2011).